Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus

Biologics: Targets and Therapy

Volumn 7, Issue 1, 2013, Pages 233-241

  Ideno, Shoji ^a,c   Sakai, Kaoru ^a   Yunoki, Mikihiro ^b,c,d   Kubota Koketsu, Ritsuko ^c,e   Inoue, Yuji ^c   Nakamura, Shota ^c   Yasunaga, Teruo ^c   Okuno, Yoshinobu ^e   Ikuta, Kazuyoshi ^c  

^a Japan Blood Products Organization   (Japan)

^b Telecommunications Advancement   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d RAKUNO GAKUEN UNIVERSITY   (Japan)

^e The Research Foundation for Microbial Diseases of Osaka University   (Japan)

Author keywords

Epitope; Hemagglutinin; Influenza A; Rabbit; Synthetic peptide

Indexed keywords

AMINO ACID; EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ; KEYHOLE LIMPET HEMOCYANIN; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BETA SHEET; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOREACTIVITY; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PEPTIDE SYNTHESIS; RABBIT;

EID: 84887142720     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/BTT.S50870     Document Type: Article

References (19)

1. Ben-Yedidia T, Arnon R. Epitope-based vaccine against influenza. Expert Rev Vaccines. 2007;6(6):939-948.
2. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69: 531-569.
3. Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009;106(48):20365-20370.
4. Yunoki M, Kubota-Koketsu R, Urayama T, et al. Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1. Br J Haematol. 2010;148(6):953-955.
5. Amendola A, Ranghiero A, Zanetti A, Pariani E. Is avian influenza virus A(H5N1) a real threat to human health? J Prev Med Hyg. 2011;52(3): 107-110.
6. Tripp RA, Tompkins SM. Recombinant vaccines for influenza virus. Curr Opin Investig Drugs. 2008;9(8):836-845.
7. Vergara-Alert J, Argilaguet JM, Busquets N, et al. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model. PLoS One. 2012; 7(7):e40524.
8. Wang TT, Tan GS, Hai R, et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A. 2010;107(44): 18979-18984.
9. Babon JA, Cruz J, Ennis FA, Yin L, Terajima M. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus. J Virol. 2012;86(17): 9233-9243.
10. Kubota-Koketsu R, Mizuta H, Oshita M, et al. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem Biophys Res Commun. 2009;387(1):180-185.
11. Yamashita A, Kawashita N, Kubota-Koketsu R, et al. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition. Biochem Biophys Res Commun. 2010;393(4):614-618.
12. Kaur K, Sullivan M, Wilson PC. Targeting B cell responses in universal influenza vaccine design. Trends Immunol. 2011;32(11):524-531.
13. Staneková Z, Varečková E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J. 2010;7:351.
14. RCSB Protein Data Bank [homepage on the Internet]. Available from: http://www.rcsb.org/pdb/home/home.do. Accessed Sep 23, 2013.
15. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol. 1990;28(6):1308-1313.
16. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington DC: National Academic Press; 1996.
17. Niederhäuser S, Bruegger D, Zahno ML, et al. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals. Vaccine. 2008;26(52):6749-6753.
18. Inoue Y, Kubota-Koketsu R, Yamashita A, et al. Induction of antiinfluenza immunity by modified green fluorescent protein (GFP) carrying hemagglutinin-derived epitope structure. J Biol Chem. 2013;288(7):4981-4990.
19. Sidwell RW, Smee DF. In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res. 2000;48(1):1-16.